Saudi Fellowship Adult Nephrology
Saudi Fellowship Final Examination - Adult Nephrology (SCFHS)
Onco Nephrology And PharmacologyEnglish
Exam overviewPractice session
A 64-year-old man with metastatic malignant melanoma is treated with the immune checkpoint inhibitor (CPI) combination nivolumab (anti-PD-1) and ipilimumab (anti-CTLA-4). Four months into therapy, routine monitoring reveals an asymptomatic rise in serum creatinine from 0.9 to 2.8 mg/dL. Urinalysis shows sterile pyuria (20–30 WBCs/hpf), white blood cell casts, and 1+ proteinuria. Renal ultrasound is unremarkable. What is the most common underlying renal histopathology of CPI-induced nephrotoxicity, and what is the recommended first-line management?
Loading your practice session…